Drugs / P1801
last change Apr 2025 re-read 2 minutes ago

P1801

Developed for
cancer
Investigated by
Efficient Pharma Management Corp. · PharmaEssentia

Trials 1 · a red edge is where a trial was stopped

2026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT07053904 Apr 2025 → Dec 2028 expected cancer PharmaEssentia Enrolling by invitation No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as P1801 ClinicalTrials.gov intervention name — accepted as the source's own label NCT07053904